Newer drugs in glaucoma management by Sujatha V Kadambi, Ronnie George

Subjects: Get full text

Evaluating the efficacy of Rho kinase inhibitor eye drops in the management of corneal edema: A single-center retrospective cohort study by Itay Lavy, Nir Erdinest, Jamel Corredores, Denise Wajnsztajn, David Smadja

Subjects: Get full text

Safety, efficacy, and patient selection of ripasudil in patients with uncontrolled glaucoma with maximum conventional medical therapy by Jignesh Jethva, Purvi Bhagat, Kamini Prajapati, Gunjan Tank

Subjects: Get full text

Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study by Bacharach J, Sadri E, Sawhney G, Kopczynski C, Merchea MM

Subjects: Get full text

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor by Jiannong Dai, Naga Pradeep Rayana, Michael Peng, Chenna Kesavulu Sugali, Devon H. Harvey, Kamesh Dhamodaran, Eric Yu, Joseph M. Dalloul, Shaohui Liu, Weiming Mao

Subjects: Get full text

Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study by Alex T. Pham, BS, Chris Bradley, PhD, Corinne Casey, OD, Henry D. Jampel, MD, Pradeep Y. Ramulu, MD, PhD, Jithin Yohannan, MD, MPH

Subjects: Get full text

Comparative investigation of antitumoral effectiveness of Rho-kinase inhibitor Y-27632, pravastatin and atorvastatin in anaplastic thyroid cancer cell culture by Erdinc Nayir, Selver Cor, Zuhal Mert Altintas, Kansu Buyukafsar, Rukiye Nalan Tiftik, Alper Ata, Ali Arican

Subjects: Get full text

Efficacy of ripasudil in reducing intraocular pressure and medication score for ocular hypertension with inflammation and corticosteroid by Ryoji Yanai, Sho-Hei Uchi, Masaaki Kobayashi, Tomohiko Nagai, Shinichiro Teranishi, Makiko Wakuta, Kazuhiro Kimura

Subjects: Get full text

Fasudil Ameliorates Methotrexate-Induced Hepatotoxicity by Modulation of Redox-Sensitive Signals by Esam M. Aboubakr, Ahmed R. N. Ibrahim, Fares E. M. Ali, Ahmed A. E. Mourad, Adel M. Ahmad, Amal Hofni

Subjects: Get full text

“Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost” by David Chung, Edward J. Meier

Subjects: Get full text

Evaluation of Rho kinase inhibitor effects on neuroprotection and neuroinflammation in an ex-vivo retinal explant model by Élodie Reboussin, Paul Bastelica, Ilyes Benmessabih, Arnaud Cordovilla, Cécile Delarasse, Annabelle Réaux-Le Goazigo, Françoise Brignole-Baudouin, Céline Olmière, Christophe Baudouin, Juliette Buffault, Stéphane Mélik Parsadaniantz

Subjects: Get full text

Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma by Sumita Mohapatra, Subhodeep Thakur, Bijnya B Panda, Priti Das

Subjects: Get full text

Double-Masked, Vehicle-Controlled, Randomized, Phase II Study of the Ocular Hypotensive Activity and Safety of VVN539 Ophthalmic Solution by David Wirta, MD, Xiao-Yan Li, MD, Wang Shen, PhD, Caroline Lu, MS, Gary D. Novack, PhD, William Christie, MD, Paul J. Hartman, MD, Lawrence Tafoya, MD, PhD, Navin Tekwani, MD, David Wirta, MD

Subjects: Get full text

Evaluation of an Intravitreal Rho-Associated Kinase Inhibitor Depot Formulation in a Rat Model of Diabetic Retinopathy by Cecile Lebon, Heike Neubauer, Marianne Berdugo, Kimberley Delaunay, Elke Markert, Kolja Becker, Katja S. Baum-Kroker, Jürgen Prestle, Holger Fuchs, Remko A. Bakker, Francine Behar-Cohen

Subjects: Get full text

A novel cell-based transplantation method using a Rho kinase inhibitor and a specific catheter device for the treatment of salivary gland damage after head and neck radiotherapy by Atsushi Kasamatsu, Reo Fukushima, Koki Nakamura, Kohei Kawasaki, Shusaku Yoshimura, Tomoyoshi Koyama, Chonji Fukumoto, Isao Miyamoto, Katsuhiro Uzawa

Subjects: Get full text

Drug- and Cell-Type-Specific Effects of ROCK Inhibitors as a Potential Cause of Reticular Corneal Epithelial Edema by Ursula Schlötzer-Schrehardt, Andreas Gießl, Matthias Zenkel, Alexander Bartsch, Naoki Okumura, Noriko Koizumi, Shigeru Kinoshita, Theofilos Tourtas, Friedrich E. Kruse

Subjects: Get full text

Current perspectives in tackling glaucoma blindness by Shibal Bhartiya, Parul Ichhpujani, Meenakshi Wadhwani

Subjects: Get full text

Netarsudil-associated epithelial keratopathy by Meera S. Ramakrishnan, Victoria M. Addis, Amanda Y. Lehman, Prithvi S. Sankar

Subjects: Get full text

Netarsudil monotherapy as the initial treatment for open-angle glaucoma and ocular hypertension in Indian patients: A real-world evaluation of efficacy and safety by Manoj Chandra Mathur, P Venkat Ratnam, S J Saikumar, Manuel John, Siddharth Ravishankar, M B Dinesh, Priya Chandil, Kishore Pahuja, Vidya Cherlikar, Sunny Wadhwani, Pankaj Bendale, Ajit Hazari, Rajesh Mishra, Susheel Deshmukh, Rahul Raja Achlerkar, Devang Tilak Shah, Chanda Hingorani, Kaivan Shah, Pratik Topiwala, Sheetal Jani, Viral G Rana, Nilay Kumar Majumdar, Debasis Chakrabarti, Rituparna Dey, Debabrata Halder, Sumit Choudhury, Ajeet Kumar, Sasmita Das, Ashok Kumar Nanda, Vidya Bhushan Kumar, Rama Dubey, Gulam Ali Kamdar, Alka Pandey, Sheetal Kishanpuria, Rajat Mohan Srivastava, Parul Singh, Sunil Kumar Verma, Neha Sharma, Rajeev Gupta

Subjects: Get full text

Influence of Rho Kinase Inhibitor Fasudil on Late Endothelial Progenitor Cells in Peripheral Blood of COPD Patients with Pulmonary Artery Hypertension by Pei Liu, Hongmei Zhang, Yijun Tang, Chunfeng Sheng, Jianxin Liu, Yanjun Zeng

Subjects: “…Rho Kinase Inhibitor Fasudil…”
Get full text